ATNM
Actinium Pharmaceuticals, Inc.
1.88
+
0.10
5.62%
10 x 1.87
9 x 1.88
bid
ask
01:46 PM
timesize
Bearish
25
Bullish
73
sentiment
1.83
day range
1.91
1.33
52 week range
10.24
News
...
Profile
...
Actinium Pharmaceuticals, Inc. develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people who have failed existing oncology therapies. Its Iomab-B is an induction and conditioning agent prior to bone marrow transplant in patients with relapsed and refractory acute myeloid leukemia (r/r AML). The company focuses on advancing its development for product candidate Actimab-A, a therapeutic agent that has demonstrated potential activity in r/r AML patients. In addition, it engages with the National Cancer Institute under the cooperative research and development agreement for the development of Actimab-A in AML and other myeloid malignancies. Its Iomab-ACT, a next generation conditioning candidate, is being developed for improving patient access and outcomes for curative cell and gene therapies. Further, the company's research and development activities primarily focus on advancing various preclinical programs for solid tumor indications. The company holds approximately 235 patents and patent applications, including various patents related to the manufacture of the isotope Ac-225 in a cyclotron. The company is based in New York, New York.
Earning
...
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-11-07 | 2024-09 | -0.35 | N/A | N/A | N/A |
2024-08-05 | 2024-06 | -0.48 | -0.38 | 0.1 | 20.83% |
2024-04-26 | 2024-03 | -0.42 | -0.31 | 0.11 | 26.19% |
2024-03-29 | 2023-12 | -0.54 | -0.33 | 0.21 | 38.89% |
2023-11-02 | 2023-09 | 0 | -0.49 | N/A | N/A |
2023-08-14 | 2023-06 | -0.5 | -0.58 | -0.08 | -16.00% |
Upgrade / Downgrade
...
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-10-02 | B. Riley Securities | Upgrade | Buy | Buy |
2023-09-06 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-09-05 | HSBC | Upgrade | Buy | |
2023-08-14 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-05-15 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-04-19 | HC Wainwright & Co. | Upgrade | Buy |
Insider Holder
...
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2019-03-04 | BERGER MARK STANLEY | Officer | 22.50K | Conversion of Exercise of derivative security |
2016-04-13 | DAVE KAUSHIK J PH.D. | Chief Executive Officer | 88.50K | Purchase |
2018-11-18 | LUDWIG DALE L | Officer | 10.00K | Purchase |
2016-08-30 | MEMORIAL SLOAN KETTERING CANCER CENTER | Beneficial Owner of more than 10% of a Class of Security | 4.71M | Sale |
2018-12-09 | O LOUGHLIN STEVE | Officer | 35.50K | Purchase |
2017-08-01 | RAY NITYA G. | Officer | 10.00K | Purchase |
Institution Ownership
...
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Blackrock Inc. | 1.70M | 12.60M | 6.29% |
2023-06-29 | Vanguard Group Inc | 1.33M | 9.90M | 4.94% |
2023-06-29 | Geode Capital Management, LLC | 521.38K | 3.87M | 1.93% |
2023-06-29 | State Street Corporation | 481.70K | 3.57M | 1.78% |
2023-06-29 | Northern Trust Corporation | 219.34K | 1.63M | 0.81% |
2023-06-29 | Dimensional Fund Advisors LP | 180.15K | 1.34M | 0.67% |
Fund Ownership
...
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 794.17K | 5.89M | 2.94% |
2023-08-30 | iShares Russell 2000 ETF | 578.21K | 3.48M | 2.14% |
2023-06-29 | Vanguard Extended Market Index Fund | 356.80K | 2.65M | 1.32% |
2023-07-30 | Fidelity Small Cap Index Fund | 230.72K | 1.64M | 0.85% |
2023-08-30 | iShares Russell 2000 Growth ETF | 199.89K | 1.20M | 0.74% |
2023-08-30 | iShares NASDAQ Biotechnology ETF | 173.24K | 1.04M | 0.64% |
Split
...
Split | Date |
---|---|
1 : 30 | 2020-08-11 |
This topic has been deleted. Only users with topic management privileges can see it.
-
Holy crap got 16,000 156% up
-
-
-
-
-
-
-
-
Target $2 on monday
-
This stock will next ibio next week will keep this stock until Target $2
-
ATNM earning call live now
-
Green monday coming up
-
Avg.at .16.1 lets do this...
-
Hold here..
-
Crazy volume wow..
-
Low vol today for sure..
-
We break 31 today..
-
This one has been on the scanners a couple days now showing some life hold tight here..
-
AGNC Investment (NASDAQ:AGNC) Stock Rating Upgraded by StockNews.com
news.google.com •